Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Operating Expenses (2020 - 2025)

Stemtech (STEK) has disclosed Operating Expenses for 6 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • Quarterly Operating Expenses fell 25.31% to $1.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Sep 2025, down 37.27% year-over-year, with the annual reading at $6.1 million for FY2024, 24.93% down from the prior year.
  • Operating Expenses hit $1.0 million in Q3 2025 for Stemtech, up from $853004.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $4.2 million in Q3 2022 to a low of $853004.0 in Q2 2025.
  • Historically, Operating Expenses has averaged $1.7 million across 5 years, with a median of $1.6 million in 2023.
  • Biggest five-year swings in Operating Expenses: skyrocketed 180.05% in 2022 and later plummeted 62.66% in 2023.
  • Year by year, Operating Expenses stood at $2.7 million in 2021, then tumbled by 55.91% to $1.2 million in 2022, then skyrocketed by 116.92% to $2.6 million in 2023, then plummeted by 60.61% to $1.0 million in 2024, then rose by 0.97% to $1.0 million in 2025.
  • Business Quant data shows Operating Expenses for STEK at $1.0 million in Q3 2025, $853004.0 in Q2 2025, and $1.9 million in Q1 2025.